News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jeffrey L. Vacirca

Articles by Jeffrey L. Vacirca

88 Eflapegrastim, a Long-Acting Granulocyte Colony–Stimulating Factor, Administered the Same Day as Chemotherapy in Patients With Early-Stage Breast Cancer: Results From a Multicenter, Open-Label Study

ByLee Schwartzberg, MD, FACP,Omkar Marathe,Shanta Chawla,Jeffrey L. Vacirca,Kenneth Crist,Howard Franklin,Manuel Modiano

April 23rd 2025

Latest Updated Articles

Trending on CancerNetwork

How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?

Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma

Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma

Leveraging Novel Software to Further Improve Personalized Cancer Care

Expert Perspectives on Bispecific Monoclonal Antibody Administration in the Community Oncology Setting

© 2025 MJH Life Sciences^®

All rights reserved.